News for RepliCel Life Sciences Inc. (REPCF)

RepliCel Announces Secured Loan Agreement VANCOUVER, BC, CANADA -April 17, 2024 - RepliCel Life Sciences Inc. , a company developing next-generation technologies in...

RepliCel announces a Letter of Intent for Asset Purchase Agreement VANCOUVER, BC, CANADA -March 18, 2024 - RepliCel Life Sciences Inc. , a company developing next-generation...

We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer: ...

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS For the three months ended March 31, 2023 and 2022 Notice of No Auditor... | May 31, 2023

RepliCel Life Sciences Announces Intention to Pay Dividend on Preferred Shares VANCOUVER, BC - January 16, 2023 - RepliCel Life Sciences Inc. , a company... | February 23, 2023

RepliCel Announces Settlement of Payment of Dividend on Preferred Shares Not for distribution to U.S. Newswire Services or for... | February 23, 2023

According to Fortune Business Insights, the global alopecia treatment market size is expected to reach USD 13.45 billion in 2027 from USD 8.89 billion in...

Trademark registrations kickoff pre-commercial planning VANCOUVER, BC, CANADA - 28 October 2021 - RepliCel Life Sciences Inc. , a company developing next-generation... | October 28, 2021

Testing progresses to next-phase; results lead to some component upgrades to ensure optimal performance, quality compliance, and commercial-scale production capabilities ... | October 27, 2021

October 19, 2021 ... | October 19, 2021

Kunihiko Suzuki, one of the leading pioneers in Japan's emerging regenerative medicine industry, commits to a role as Senior Strategic Advisor to RepliCel's Board of Directors ... | October 12, 2021